
Evolent Health (EVH) Stock Forecast & Price Target
Evolent Health (EVH) Analyst Ratings
Bulls say
Evolent Health is supported by accelerating Performance Suite execution, with 3Q26 revenue of $725.4mm up 51.3% Y/Y and adjusted EBITDA of $34.3mm exceeding expectations, while favorable runout on 2026 launches like Highmark and Aetna suggests reserves are proving conservative. Its outlook is strengthened by contract wins and expansions, including a 4-year Surgical Management renewal, a ~1mm life oncology expansion, and a national payer relationship now spanning 50 states, all of which reinforce the company’s value-based care platform. Fundamentally, the shift toward margin and cash generation is encouraging, with FY26 EBITDA guidance lifted to a $130mm-$135mm range, FY27 adjusted EBITDA reiterated at $150mm+, free cash flow of $19.2mm in 3Q, and up to $50mm of YE debt reduction targeted.
Bears say
Evolent Health is facing a negative setup because its HCIT exposure depends on government-supported spending and value-based care adoption that could slow, while hospital budget pressure, customer losses from consolidation, and greater price competition may restrain demand. The company also flagged slower client signings, existing clients shifting to other vendors, and a roughly 7% membership headwind in Technology & Services, which translates into an approximately 11-12% revenue decline there, including Medicaid and pricing pressure. Although 2026/2027 revenue estimates were raised to $2.63/$3.28 billion and adjusted EBITDA to $131/$150 million, cash from adjustments will not arrive until next year, and management indicated that some potential contracts are not included in the roughly 25% growth framework, leaving EBITDA upside uncertain.
This aggregate rating is based on analysts' research of Evolent Health and is not a guaranteed prediction by Public.com or investment advice.
Evolent Health (EVH) Analyst Forecast & Price Prediction
Start investing in Evolent Health (EVH)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Evolent Health (EVH) Forecast
Evolent Health (EVH) Analyst Forecast & Price Prediction
Start investing in Evolent Health (EVH)
Order type
Buy in
Order amount
Est. shares
0 shares